AstraZeneca, FibroGen’s roxadustat hit with tough safety questions in FDA review ahead of key expert meeting aliu Tue, 07/13/2021 – 11:16 More: AstraZeneca, FibroGen's roxadustat hit with tough safety questions in FDA review ahead of key expert meeting Source: fierce
read moreCompany’s molecular testing platform and first assay panel can now be marketed in the EU More: Quidel gains CE mark for combined COVID-19, flu and RSV diagnostic test Source: News
read moreIn 2020, the two partners announced an initial collaboration to integrate Cegedim’s ‘THIN’ European real-world data into Aetion’s evidence platform More: Aetion and Cegedim expand real-world data partnership Source: News
read moreResearchers discover presence of ‘autoantibodies’ in people with persistent COVID-19 symptoms More: New hope for long COVID blood tests after antibody discovery Source: News
read moreSMC was unable to accept Pfizer’s Vyndaqel for use in patients with transthyretin amyloidosis More: Tecentriq, Kesimpta lead latest SMC decisions Source: News
read moreGilead’s Veklury shows ‘no antiviral effects’ against COVID-19 in small WHO study nhigginsdunn Mon, 07/12/2021 – 14:59 More: Gilead's Veklury shows 'no antiviral effects' against COVID-19 in small WHO study Source: fierce
read more© 1994 - 2026 B.M. Pharmaceuticals